Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5024 USD | +1.07% |
|
-11.88% | -84.30% |
05-22 | Maxim Downgrades Virpax Pharmaceuticals to Hold From Buy | MT |
05-15 | Virpax Prices Public Offering of Shares, Warrants; Shares Tumble | MT |
Business Summary
Number of employees: 7
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Gudin
FOU | Founder | 58 | 16-12-31 |
Gerald Bruce
CEO | Chief Executive Officer | 68 | 17-07-31 |
Vinay Shah
DFI | Director of Finance/CFO | 62 | 23-06-19 |
Sheila Mathias
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Bruce
CEO | Chief Executive Officer | 68 | 17-07-31 |
Jeffrey Gudin
FOU | Founder | 58 | 16-12-31 |
Barbara Ruskin
BRD | Director/Board Member | - | 23-03-23 |
Eric Floyd
CHM | Chairman | 62 | 16-12-31 |
Jerrold Sendrow
BRD | Director/Board Member | 79 | 16-12-31 |
Vanila Singh
BRD | Director/Board Member | 53 | 20-05-31 |
Director/Board Member | 60 | 16-12-31 | |
Michael Dubin
BRD | Director/Board Member | 68 | 21-07-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,741,600 | 2,440,340 ( 89.01 %) | 0 | 89.01 % |
Company contact information
![address Virpax Pharmaceuticals, Inc.(VRPX)](https://cdn.zonebourse.com/static/address/119073351.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.30% | 582K | |
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- VRPX Stock
- Company Virpax Pharmaceuticals, Inc.